Skip to content

BasIQ-4® a new approach towards performing episiotomy

BasIQ-4® a new approach towards performing episiotomy. Post Market Clinical Follow-Up Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21926
Enrollment
100
Registered
2020-05-06
Start date
2020-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

women pregnant and scheduled to deliver “at term” of a fetus in cephalic presentation

Interventions

The “BasIQ-4” is designed to perform a (medio)lateral episiotomy of approximately 4 cm

Sponsors

BasIQ B.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women aged 18 years and older who are pregnant and scheduled to deliver “at term” of a fetus in cephalic presentation and intend to deliver vaginally (for the first time) and who are willing and able to give written informed consent.

Exclusion criteria

Exclusion criteria: Insufficient knowledge of the local language Prior vaginal delivery in anamnesis Coagulation disorders Expected wound healing problems diabetes mellitus venous insufficiency immune suppression (e.g. HIV infected women, women using immunosuppressive drugs) Thrombocytopenia pre-eclampsia/HELPP syndrome Forceps delivery Vulnerable people

Design outcomes

Primary

MeasureTime frame
to further evaluate and monitor the safety and performance of the “BasIQ-4®” in a population of women delivering in general hospitals in The Netherlands when used as intended

Secondary

MeasureTime frame
• To confirm the acceptability of the identified residual risks associated with the use of the “BasIQ-4®”. • To identify not yet identified risks. • To generate results with this study that will initiate further scientific investigation especially between the BasIQ-4® and episiotomy scissors.

Contacts

Public ContactMariette Schrier

BasIQ B.V.

schrier@iq-medicalventures.com0031 (0)10 2619100

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)